| On cell loss and selective vulnerability of neuronal populations in Parkinson's disease S Burke, N Giguère, LE Trudeau Frontiers in neurology, 455, 2018 | 434 | 2018 |
| Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals? S Burke, YC Wong, K Luk, K Purtell, AJ Stoessl, LE Trudeau, Z Yue, ... Movement Disorders 34 (10), 1406-1422, 2019 | 114 | 2019 |
| Dopaminergic neurons establish a distinctive axonal arbor with a majority of non‐synaptic terminals C Ducrot, MJ Bourque, CVL Delmas, AS Racine, D Guadarrama Bello, ... The FASEB Journal 35 (8), e21791, 2021 | 31 | 2021 |
| Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice B Delignat-Lavaud, J Kano, C Ducrot, I Massé, S Mukherjee, N Giguère, ... Nature communications 14 (1), 4120, 2023 | 16 | 2023 |
| Amphetamine disrupts dopamine axon growth in adolescence by a sex-specific mechanism in mice LM Reynolds, G Hernandez, D MacGowan, C Popescu, D Nouel, ... Nature communications 14 (1), 4035, 2023 | 15 | 2023 |
| The calcium sensor synaptotagmin-1 is critical for phasic axonal dopamine release in the striatum and mesencephalon, but is dispensable for basic motor behaviors in mice B Delignat-Lavaud, J Kano, C Ducrot, I Massé, S Mukherjee, N Giguère, ... bioRxiv, 2021 | 12 | 2021 |
| On cell loss and selective vulnerability of neuronal populations in Parkinson’s disease. Front Neurol 2018; 9: 455 N Giguere, S Burke Nanni, LE Trudeau Epub 2018/07/05. https://doi. org/10.3389/fneur. 2018.00455 PMID: 29971039, 2018 | 11 | 2018 |
| Impact of concanavalin-A-mediated cytoskeleton disruption on low-density lipoprotein receptor-related protein-1 internalization and cell surface expression in glioblastomas S Burke, J Pratt, D Beauchemin, K Haidara, B Annabi Biomarkers in cancer 8, BIC. S38894, 2016 | 9 | 2016 |
| Axonal domain structure as a putative identifier of neuron-specific vulnerability to oxidative stress in cultured neurons S Burke, LE Trudeau Eneuro 9 (5), 2022 | 6 | 2022 |
| Neurexins regulate GABA co-release by dopamine neurons C Ducrot, G de Carvalho, B Delignat-Lavaud, CVL Delmas, N Giguère, ... bioRxiv, 2021.10. 17.464666, 2021 | 4 | 2021 |
| Amphetamine disrupts dopamine axon growth in adolescence by a sex-specific mechanism LM Reynolds, G Hernandez, C Popescu, D MacGowan, D Nouel, ... bioRxiv, 2022.12. 14.520468, 2022 | 3 | 2022 |
| On cell loss in Parkinson’s disease, and the citations that followed S Burke, LE Trudeau npj Parkinson's Disease 8 (1), 38, 2022 | 1 | 2022 |
| Protocols for" Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice" B Delignat-Lavaud, J Kano, C Ducrot, I Massé, S Mukherjee, N Giguère, ... | | 2023 |
| Neurochemical identity and anatomy of cell loss in Parkinson’s disease, and the clinical data available for correlation of progression : a systematic review and meta-analysis Samuel Burke, William Lunt, Nathan Skene, Julian Higgins, Sarah Dawson ... Prospero: International prospective register of systematic reviews …, 2021 | | 2021 |